GUERRA LUCA

Durmo, R., Chauvie, S., Minoia, C., Bergesio, F., Fallanca, F., Peano, S., et al. (2025). Total Metabolic Tumor Volume Is a Strong Independent Prognostic Factor in Follicular Lymphomas: Results From a Sub‐Study of the FOLL12 Trial. AMERICAN JOURNAL OF HEMATOLOGY [10.1002/ajh.27711]. Dettaglio

Durmo, R., Chauvie, S., Fallanca, F., Bergesio, F., Pinto, A., Del Giudice, I., et al. (2025). Prognostic role of interim PET in patients with follicular lymphoma: a post-hoc study of FOLL12 trial by FIL. BLOOD ADVANCES [10.1182/bloodadvances.2024014790]. Dettaglio

Boellaard, R., Buvat, I., Nioche, C., Ceriani, L., Cottereau, A., Guerra, L., et al. (2024). International Benchmark for Total Metabolic Tumor Volume Measurement in Baseline 18F-FDG PET/CT of Lymphoma Patients: A Milestone Toward Clinical Implementation. THE JOURNAL OF NUCLEAR MEDICINE, 65(9), 1343-1348 [10.2967/jnumed.124.267789]. Dettaglio

Guerra, L., Chauvie, S., Fallanca, F., Bergesio, F., Marcheselli, L., Durmo, R., et al. (2024). End of induction [18F]FDG PET is prognostic for progression-free survival and overall survival in follicular lymphoma patients enrolled in the FOLL12 trial. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 51(11), 3311-3321 [10.1007/s00259-024-06765-z]. Dettaglio

Massironi, S., Franchina, M., Ippolito, D., Elisei, F., Falco, O., Maino, C., et al. (2024). Improvements and future perspective in diagnostic tools for neuroendocrine neoplasms. EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 19(4), 349-366 [10.1080/17446651.2024.2363537]. Dettaglio